Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Critical Care
    • CT head can predict...

    CT head can predict treatment strategy in cerebral edema patients

    Written by Medha Baranwal Baranwal Published On 2018-05-17T19:30:32+05:30  |  Updated On 17 May 2018 7:30 PM IST
    CT head can predict treatment strategy in cerebral edema patients

    In patients with subdural hematoma with cerebral edema, measurement of head computed tomography (CT) in Hounsfield units (HU) of white matter (WM) might be a useful predictor of outcome and treatment strategy, suggests a new study published in the Scandinavian Journal of Trauma, Resuscitation, and Emergency Medicine. This means that a variable application of CT Head can be extremely useful for evolving a strategy of treatment of subdural hematoma with cerebral edema.


    The study was conducted by Hitoshi Yamamura, from Graduate School of Medicine, Hirosaki University, Hirosaki city, Japan, and colleagues to evaluate whether differences in computed tomography measurements in HU of white matter and gray matter can be used as a predictor of outcome in patients with subdural hematoma with cerebral edema. The ability to predict outcome in patients with cerebral edema is important because it can influence treatment strategy.

    Severe brain injury results in high morbidity and mortality in trauma patients. If excessive brain edema occurs, it can become uncontrollable and cause secondary brain damage. The assessment of traumatic cerebral edema is difficult. Vasogenic edema caused by the destruction of the blood-brain barrier and increased vascular permeability is a result of serum ingredients leaking outside the capillaries.


    Previous studies have reported on the assessment of brain edema using quantitative CT, perfusion CT, magnetic resonance imaging, and transcranial Doppler. However, there are few reports that correlate cerebral edema with the prediction of outcome. The HUof white matter in patients with head trauma correlated with specific gravity values measured in surgical specimens.


    For the study, the investigators evaluated 34 patients who had subdural hematoma with cerebral edema following acute closed head trauma and had undergone head CT within a few hours of admission. The patients were divided into the survival (n = 24) group and death (n = 10) group and measured the HU of white matter and gray matter at injury and non-injury sites.



    Key Findings:




    • There were no significant differences in operation time or blood loss during surgery between the two groups.

    • Only the HU of white matter in the injury site of patients in the death group was decreased significantly.

    • A cut-off value of 31.5 for HU of white matter showed 80.0 % sensitivity and 99.9 % specificity for death.




    HU values in WM may be one factor in the decision-making process that affects patient outcome. Changing the treatment strategy in patients with a low HU value in the WM at the injury site may bring about an improvement in patient outcome.


    Based on the findings the researchers concluded that the measurement of HU values in WM at the injury site might be useful as a predictor of outcome in patients with subdural hematoma with cerebral edema. An effective treatment plan needs to be formulated in high-risk patients in whom the HU value of WM is below 31.5.






    For further information click on the link: https://doi.org/10.1186/s13049-016-0271-y

    brain damageBrain Edemabrain injuryCerebral Edemacomputed tomographicComputed tomographyCTDr Hitoshi Yamamuragray matterhead CThematomaHitoshi YamamuraHounsfieldHounsfield unitsHUneurologyradiologyScandinavian Journal of Trauma Resuscitation and Emergency MedicineSubdural Hematomatraumatraumatic brain injurywhite matter
    Source : With inputs from SJTREM

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok